Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Cohort 1 – Newly diagnosed brain tumor (up to 30 participants)
- Children and young people aged 4 to 18 years old
- Recently diagnosed with a primary brain tumor of any type or location
- Expected to live for at least one year
- Able to understand the study and willing to agree to take part, with a parent or guardian's agreement if required
Cohort 2 – Posterior fossa brain tumor (up to 150 participants)
- Children and young people aged 4 to 18 years old
- Previously diagnosed with a brain tumor in the lower back part of the brain (called the posterior fossa), whether currently receiving treatment or having already finished treatment
- Expected to live for at least one year
- Able to understand the study and willing to agree to take part, with a parent or guardian's agreement if required
Cohort 3 – Posterior fossa syndrome (up to 20 participants)
- Children and young people aged 4 to 18 years old
- Previously diagnosed with a brain tumor in the lower back part of the brain (posterior fossa)
- Diagnosed with a condition called posterior fossa syndrome after surgery (a condition that can affect speech, movement, and behaviour following certain brain surgeries)
- Unable to complete a specific set of computer-based tests called the NIH Toolbox
- Expected to live for at least one year
- Able to understand the study and willing to agree to take part, with a parent or guardian's agreement if required
Cohort 4 – Long-term follow-up (up to 50 participants)
- People aged 12 to 30 years old
- Diagnosed with a brain tumor more than 3 years before joining the study
- Expected to live for at least one year
- Able to complete a 1-hour MRI scan without needing sedation (medication to make someone drowsy or sleep)
- Able to understand the study and willing to agree to take part, with a parent or guardian's agreement if required
Who may not be able to join:
Cohorts 1 and 2
- People whose vision is impaired to the point where completing computer-based tests would not be possible
- People who are unable to have an MRI scan for medical reasons, such as having a cardiac pacemaker (a device implanted in the chest to help the heart beat)
- People who have a programmable shunt (a device implanted in the brain to drain fluid, with adjustable settings) — this applies to Cohort 1 only
Cohort 3
- People who are unable to have an MRI scan for medical reasons, such as having a cardiac pacemaker
Cohort 4
- People who are unable to have an MRI scan for medical reasons, such as having a cardiac pacemaker
- People who wear dental braces or have a programmable shunt
- People who require sedation in order to undergo an MRI scan
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Stephanie Perkins, M.D., Washington University School of Medicine
Phone: 314-273-2931
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Identify reliable peri-diagnostic estimators of cognition as measured by neurocognitive testing; Identify reliable peri-diagnostic estimators of cognition as measured by advanced resting-state functional connectivity MRI (rsfcMRI) data; Predictors of cognitive recovery in children as determined by multiplexed analyses of a combination of potential biomarkers across multiple modalities (rsfcMRI, structural MRI, NIH Toolbox, patient demographics, treatment information); Identify reliable peri-diagnostic estimators of brain function as measured by neurocognitive testing; Identify reliable peri-di...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.